Editorial
 108 DRUGS MORE UNDER DPCO   
 Wednesday, July 23, 2014 
 National Pharmaceutical Pricing Authority, early this month, brought 108 essential drugs more under the ambit of Drug Price Control Order, 2013 in addition to 348 drugs already under price control. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]NIH study shows schizophrenia’s genetic rising to a new level
17:15  [IST]Bristol-Myers Squibb appoints Jitendra Tyagi as India country head
17:00  [IST]MetaMax enrolls first patient in phase 1/2a study of anti-cancer drug MM-D37K
16:00  [IST]McCord Research endothelial cell treatment receives US patent
15:00  [IST]Glide Pharma completes proof-of-concept study with novel solid dose formulation of octreotide
14:20  [IST]Strides Arcolab gets USFDA nod for Tacrolimus Capsules
more news >>
TOP NEWS
08:00  [IST]PCI disapproves 2-year full-time MS programmes in various pharmacy streams
08:00  [IST]Exporters want India & Vietnam to work together on addressing drug testing issues in Vietnam
08:00  [IST]Speedy issuance of drug mfg licences implemented at Pune followed by Konkan division
08:00  [IST]Use of IT in Indian healthcare muted, but set to gain momentum: NATHEALTH president & Fortis vice chairman
08:00  [IST]Odisha to emerge leading health services destination of East India: Dr Harsh Vardhan
08:00  [IST]DCGI sets up Independent Expert Committee on Oncology for trial deaths caused by cancer drugs
more news >>
YESTERDAY'S NEWS
18:15  [IST]RB India launches new RingGuard Advance for fast relief from ringworm infections
18:00  [IST]US FDA accepts Medicines360's NDA for Levosert IUC
17:45  [IST]Siemens installs 'Aptio automation solution' lab at Thyrocare
17:15  [IST]Philips Healthcare appoints Sameer Garde as president, South Asia
17:00  [IST]Celsion gets $1 mn career development award grant from NIH for glioblastoma research with ThermoDox and HIFU
16:00  [IST]US FDA accepts Avanir Pharma's IND application for phase II study of AVP-786 for adjunctive treatment of MDD
more news >>
INTERVIEW  
There is light at the end of the tunnel for the Indian clinical trial industry
Global clinical research organizations, leading international research centers and the bio pharma abroad are keen to conduct the human studies on the Indian patient population.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |